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Antibacterial activityAbstract [1+4] Cycloaddition reaction of ethylene ether-based N,N-dimethybenzylidenebarbituric
acid with alkyl isocyanide in DMF produced novel high substituted furo[2,3-d]pyrimidine deriva-
tives containing ether spacers under mild reaction conditions. The structures of the products were
deduced from their IR, 1H NMR, and 13C NMR spectroscopy. Good antibacterial activity was
found in compound 5c.
 2016 King Saud University. Production and hosting by Elsevier B.V. This is an open access article under
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It is well known that fused pyrimidine systems represent a very
interesting class of compounds because of their diverse chem-
istry [1]. Also, they have many important biological properties
such as antitumor and antibacterial [2–4], antimalarial [5] and
antifolate activities [6]. Moreover, they are used as potential
radiation protection agent [7]. Among these systems, furo
[2,3-d]pyrimidine ring system is of biological interest; thus,these derivatives have been reported as the inhibitors of dihy-
drofolatereductase, thymidylate synthase, antitumor agents,
antiprotozoan agents, antibacterial [8–10] and anti-HCMV
(human cytomegalovirus) [11]. Also, some furo-pyrimidines
were shown to be potent VEGFR2 (vascular endothelial
growth factor receptor 2), EGFR (epidermal growth factor
receptor) [12] and kinase [13–15] inhibitors.
Synthesis of furo-pyrimidines has received little attention
and only few procedures have been reported in the literature
[16–26], most of which rely on multi-step reactions with low
yields. The existence of a lipophilic group in the furo-
pyrimidine structure has been shown to improve the biological
activity of these compounds [27,28]. Based on the above infor-
mation, in the present investigation, a series of novel furo-
pyrimidine derivatives containing hydrophobic ethylene ether
spacers was designed and synthesized by the reaction of
ethylene glycol-substituted benzylidenebarbituric acid with
isocyanides.s, Jour-
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Scheme 1 Synthesis of benzylidenebarbituric derivatives containing ethylene ether spacers.
2 E. Sheikhhosseini2. Experimental
2.1. General
Commercially available materials were used without further
purification. Melting points were determined on an Elec-
trothermal 9100 apparatus and were uncorrected. IR spectra
were obtained on an ABB FT-IR FTLA 2000 spectrometer.
1H NMR and 13C NMR spectra were run on Brukerspectrom-
eters at 400 MHz for 1H NMR and 100 MHz for 13C NMR.
CDCl3 and DMSO-d6 were applied as solvents.
2.2. General procedure for the synthesis of benzylidenebarbituric
acid derivatives containing ethylene ether spacers 3a–d
A mixture of ethylene ether based dialdehyde derivatives 1a–d
(5 mmol) and barbituric acid derivatives 2 (10 mmol) in etha-
nol (10 mL) was heated at reflux for 4–5 h. Upon cooling, solid
materials were precipitated from the solution. These precipi-
tates were filtered off, washed with hot water, and recrystal-
lized from EtOH to afford pure products 3a–d [29].
2.3. General procedure for the synthesis of furo-[2,3-d]
pyrimidine derivatives containing ethylene glycol spacers 5a–f
To the magnetically stirred benzylidenebarbituric derivatives
(1 mmol) in DMF (10 mL), alkyl isocyanide (2 mmol) was
added via a syringe and heated for 24-30 h at 50 C. After
the completion of the reaction (monitored by TLC), the solu-
tion was evaporated and diluted with H2O and the precipitated
solid product was recrystallized from water/acetone in several
times.
1,2-Bis(2-(6-(cyclohexylamino)-1,3-dimethylfuro[2,3-d]pyri
midine-2,4(1H,3H)-dione)phenoxy)ethane 5a: Yield 53%.3a-d
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Scheme 2 Synthesis of furo-[2,3-d]pyrimidine d
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(400 MHz, CDCl3) d: 1.268–1.76 (m, 20H, 10CH2), 3.18,
3.23, 3.18 and 3.30 (s, 12H, 4N–CH3), 3.45–3.47 (m, 2H,
NH), 3.77–3.79 (m, 2H, CH–N), 4.29 (t, J= 6.8 Hz, 2H,
CH2–O), 4.49 (t, J= 6.8 Hz, 2H, CH2–O), 6.86–6.95 (m, 2H,
H-arom.), 7.05 (t, J= 6.4 Hz, 2H, H-arom), 7.30–7.33 (m,
4H, H-arom. H). 13C NMR (100 MHz, CDCl3) d: 24.3, 24.6,
25.5, 32.4, 32.6, 32.7, 48.8, 48.9, 66.4, 88.5, 110.4, 112.8,
120.9, 121.3, 121.4, 121.5, 121.6, 128.5, 129.8, 129.9, 130.7,
136.0, 155.3 and 155.8. Anal. Calc. for C42H48N6O8 (764.35):
C, 65.95; H, 6.33; N, 10.99. Found: C, 66.46; H, 6.48; N,
11.36.
1,2-Bis(4-bromo-2-(6-(cyclohexylamino)-1,3-dimethylfuro[2,
3-d]pyrimidine-2,4(1H,3H)-dione)phenoxy)ethane 5b: Yield
57%. M.p. = 73–78 C. IR (KBr, cm1): 3364, 1679, 1621.
1H NMR (400 MHz, CDCl3) d: 1.14–1.93 (m, 20H, 10CH2),
3.32–3.39 (m, 18H, 4N–CH3, 2CH2O, 2NH), 3.73–3.75 (m,
2H, CH–N), 6.67 (d, J= 8.4 Hz, 2H, H-arom), 7.15–7.19
(m, 2H, H-arom), 7.41 (d, J= 2.4 Hz, 2H, H-arom). 13C
NMR (100 MHz, CDCl3) d: 24.4, 24.5, 25.2, 31.7, 32.2, 49.9,
77.2, 87.6, 112.4, 118.8, 127.2, 129.6, 129.7, 129.8, 3131.9,
153.4, 162.7. Anal. Calc. for C42H46Br2N6O8 (920.17): C,
54.67; H, 5.03; N, 9.11. Found: C, 54.98; H, 5.33; N, 8.72.
1,2-Bis(4-bromo-2-(6-(tert-butylamino)-1,3-dimethylfuro[2,
3-d]pyrimidine-2,4(1H,3H)-dione)phenoxy)ethane 5c: Yield
62%. M.p. = 218–222 C. IR (KBr, cm1): 3344, 1681, 1632.
1H NMR (400 MHz, CDCl3) d: 1.23 (s, 9H, t-but), 1.28 (s,
9H, t-but), 2.87 (s, 6H, 2N–CH3), 2.94 (s, 6H, 2N–CH3),
3.32 (s, 2H, NH), 4.33 (s, 4H, 2CH2–O), 6.96 (d, J= 8.4,
2H, H-arom), 7.51 (br s, 2H, H-arom), 7.54 (dd, J= 8.4,
1.6 Hz, 2H, H-arom). 13C NMR (100 MHz, CDCl3) d: 28.1,
28.2, 28.3, 28.6, 51.5, 67.2, 112.8, 120.9, 121.3, 128.7, 130.8,
131.3, 133.9, 134.2, 161.7, 162.6. Anal. Calc. for
C38H42Br2N6O8 (868.14): C, 52.43; H, 4.86; N, 9.65. Found:
C, 52.64; H, 4.73; N, 9.23.R = Cyclohexyl, t-Butyl
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Design and synthesis of novel furo[2,3-d]pyrimidine derivatives 31,2-Bis(2-(2-(6-(cyclohexylamino)-1,3-dimethylfuro[2,3-d]
pyrimidine-2,4(1H,3H)-dione)phenoxy)ethoxy)ethane 5d:
Yield 46%. M.p. = 75–80 C. IR (KBr, cm1): 3344, 1678.
1H NMR (400 MHz, CDCl3) d: 1.08–1.97 (m, 20H,
10CH2), 3.23 (m, 2H, CH–N), 3.31 (s, 6H, 2N–CH3), 3.37
(m, 2H, NH), 3.64 (s, 6H, 2N–CH3), 3.71–3.81 (m, 8H,
4CH2–O), 4.14–4.20 (m, 4H, 2CH2–O), 6.87 (d, J= 8.0 Hz,
2H, H-arom.), 7.0–7.04 (m, 4H, H-arom), 7.46 (t,
J= 8.0 Hz, 2H, H-arom). 13C NMR (100 MHz, CDCl3) d:
24.7, 24.9, 25.0, 25.4, 27.9, 32.7, 32.8, 48.4, 48.5, 68.0,
69.4, 70.6, 70.8, 112.2, 112.3, 113.5, 120.7, 121.9, 128.1,
129.9, 131.0, 132.3, 134.3, 150.8, 156.8, 162.6. Anal. Calc.
for C46H56N6O10 (852.41): C, 64.77; H, 6.62; N, 9.85. Found:
C, 64.36; H, 6.86; N, 9.41.Table 1 Synthesis of furo-[2,3-d]pyrimidine derivatives co
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pyrimidine-2,4(1H,3H)-dione)phenoxy)ethoxy)ethane 5e:
Yield 50%. M.p. = 90–95 C. IR (KBr, cm1): 3344, 1670
and 1630. 1H NMR (400 MHz, CDCl3) d: 1.22 (s, 18H, 2t-
but), 3.29 (s, 6H, 2N–CH3), 3.47 (s, 6H, 2N–CH3), 3.60 (s,
2H, NH), 3.68 (t, J= 4.4 Hz, 4H, 2CH2O), 3.73–3.75 (m,
4H, 2CH2–O), 4.05–4.09 (m, 4H, 2CH2–O), 6.88 (d,
J= 8.4 Hz, 2H, H-arom.), 6.99 (t, J= 7.4 Hz, 2H, H-arom).
7.19–7.21 (m, 2H, H-arom), 7.33–7.38 (m, 2H, H-arom). 13C
NMR (100 MHz, CDCl3) d: 28.6, 29.3, 30.0, 54.0, 68.2, 69.6,
70.6, 96.0, 111.2, 112.7, 121.1, 128.8, 131.1, 132.8, 149.2,
150.6, 154.9, 155.9, 158.0. Anal. Calc. for C42H56N6O10
(800.37): C, 62.99; H, 6.54; N, 10.49. Found: C, 63.14; H,
6.66; N, 10.68.ntaining ethylene ether spacers.
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Scheme 3 Proposed mechanism.
4 E. Sheikhhosseini1,2-Bis(2-(4-bromo-2-(6-(tert-butylamino)-1,3-dimethylfuro
[2,3-d]pyrimidine-2,4(1H,3H)-dione)phenoxy)ethoxy)ethane
5f: Yield 38%. M.p. = 204–206 C. IR (KBr, cm1): 3427,
1707 and 1665. 1H NMR (400 MHz, DMSO-d6) d: 0.99 (s,
18H, 2t-but), 3.18 (s, 6H, 2N–CH3), 3.40 (s, 6H, 2N–CH3),
3.52 (br s, 4H, 2CH2–O), 3.65 (br s, 4H, 2CH2–O), 4.01 (br
s, 4H, 2CH2–O), 3.11 (s, 2H, NH), 7.04 (d, J= 8.8 Hz, 2H,
H-arom), 7.43–7.45 (m, 2H, H-arom), 7.45 (d, J= 2.0 Hz,
2H, H-arom). 13C NMR (100 MHz, DMSO-d6) d: 27.7, 28.2,
29.1, 29.8, 53.2, 67.9, 68.7, 69.6, 111.4, 114.0, 122.0, 130.1,
134.0, 148.8, 149.9, 154.8, 157.2. Anal. Calc. for
C42H50Br2N6O10 (956.2): C, 52.62; H, 5.26; N, 8.77. Found:
C, 52.94; H, 5.44; N, 9.01.
2.4. Antibacterial activity determination
In Vitro antibacterial activity of the 1,2-bis(4-bromo-2-(6-(tert-
butylamino)-1,3-dimethylfuro[2,3-d]pyrimidine-2,4(1H,3H)-di
one)phenoxy)ethane 5c was investigated in different concentra-
tions (6.25, 12.5, 25 and 50 mg/ml) against four pathogenic
bacterial strains, two Gram-positive (Staphylococcus aureus
and Bacillus cereus) and two Gram-negative (Escherichia coli
and Pseudomonas aeruginosa) by the agar disc diffusion
method. Mueller-Hinton sterile agar plates (MHA) were
seeded with bacterial strains (108 CFU/ml). Sterile 6-mm diam-
eter filter paper discs were impregnated with different concen-
trations of the 5c and were placed on to MHA medium [33].
After 18–24 h of incubation at 37 C, the diameter of the clear
zone around the disc was measured and expressed inTable 2 Antibacterial activity of 5c against indicator bacterial stra
Comp. Microorganism Inhibition zone in mm
6.25(mg/ml)
5C S. aureus 10 ± 0.577
E. coli 0
P. aeruginosa 8 ± 0.288
B. cereus 8 ± 0.577
±Standard deviation.
Please cite this article in press as: E. Sheikhhosseini, Design and eﬀective synthesis of
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were carried out under similar conditions using Ceftriaxone,
Tetracycline, Amoxycillin and Doxycycline for antibacterial
activity as standard drugs. Each test was performed in
triplicate.
3. Results and discussion
In connection with our previous work on the reaction of iso-
cyanides with electron-deficient heterodienes (arylidene and
alkylidene Meldrum,s acid) [30–32], benzylidenebarbituric acid
derivatives containing ethylene ether spacers were obtained
from the reaction of dialdehyde 1 and N,N-dimethyl barbituric
acid [29] (Scheme 1).
Then, treatment of 1,2-bis(2-(2-((tetrahydro-1,3-dimethyl-
2,4,6-tri-oxopyrimidin-5(6H)-ylidene)methyl)phenoxy) ethoxy)
ethane 3c and cyclohexylisocyanide 4a was selected as a model
reaction in DMF at room temperature (Scheme 2).
The desired product 5d was isolated in 46% yield (Table,
Entry 4). Encouraged by this result, we turned our attention
to other substituted 5 and isocyanides. Thus, all the ethylene
ether based benzylidenebarbituric acid 3 and alkyl isocyanides
4 in DMF at room temperature underwent a smooth 1:2
cycloaddition reaction to give new furo[2,3-d]pyrimidine
derivatives 5a–f in 38–62% yields (Table 1, Scheme 2).
The structures of compounds 5a–f were deduced from ele-
mental analysis, IR, 1H and 13C NMR spectra. For example,
the IR spectrum of compound 5e had an absorption band cor-ins.
12.5(mg/ml) 25(mg/ml) 50(mg/ml)
15 ± 0.288 16 ± 0.763 20 ± 0.5
0 10 ± 0.577 15 ± 0.763
11 ± 0.5 13 ± 0.288 17 ± 0.5
8 ± 0.577 9 ± 0.288 11 ± 0.288
novel furo[2,3-d]pyrimidine derivatives containing ethylene ether spacers, Jour-
Table 3 Antibacterial activity of the different antibiotics against indicator bacterial strains.
Microorganism Inhibition zone in mm
Ceftriaxone Amoxycillin Doxycycline Tetracycline
S. aureus 170 ± 0.577 16 ± 0.288 25 ± 0.5 20 ± 0.5
E. coli 22 ± 0.577 11 ± 0.288 0 ± 0 0 ± 0
P. aeruginosa 21 ± 0.288 0 ± 0 0 ± 0 0 ± 0
B. cereus 0 ± 0 0 ± 0 22 ± 0.288 15 ± 0.288
±Standard deviation.
Design and synthesis of novel furo[2,3-d]pyrimidine derivatives 5responding to amine NH bond (3344 cm1), as well as bands
characteristic of carbonyl functions (1670 and 1630).
The 1H NMR spectrum of 5e exhibited three single sharp
lines readily recognized as arising from two tert-butyl
(d= 1.22 ppm) and two sets of N-methyl groups (d= 3.29
and 3.47 ppm). It also showed a triplet (d= 3.68) and two
multiple signal (d= 3.73–3.75 and d= 4.05–4.09) for the
methylene protons and singlet signal at d= 3.60 ppm for the
–NH moiety.
The synthesis of ethylene ether-based furo-pyrimidines 5
can be rationalized by initial formation of a conjugated
electron-deficient heterodyne 3 by a Knoevenagel condensa-
tion of the N, N-dimethylbarbituric acid 2 and dialdehyde 1.
Then the [4 + 1] cycloaddition reaction of the electron-
deficient heterodiene moiety of 3 (ethylene ether-based benzyli-
denebarbituric acid) with isocyanide 4 produced an iminolac-
tone intermediate 6. The subsequent isomerization of
iminolactone 6 leads to formation of product 5 (see Scheme 3).
Antibacterial potential of 5c was tested against bacterial
strains and the results are presented in Table 2. The verifica-
tion of antibacterial activity data revealed that 5c has good
bactericidal properties against S. aureus, P. aeruginosa, E. coli,
and B. cereus bacterial strains. The antibacterial activity
increased with increase in concentration of 5c. The results
regarding the antibacterial activity of the different antibiotics
are indicated in Table 3.
The inhibition zone numbers are the average of three time
independent experiments.
In conclusion reaction of ethylene ether-based benzyli-
denebarbituric acid derivatives with alky isocyanide in DMF
without needing a catalyst, provides a convenient and efficient
synthesis of furo[2,3-d]pyrimidine derivatives containing ethy-
lene ether spacers. Having neutral condition, room tempera-
ture, easy procedure and reactions could make this technique
a suitable synthesis method for new functionalized derivatives
of furo-pyrimidines.1,2-Bis(4-bromo-2-(6-(tert-butylamino)-1,
3-dimethylfuro[2,3-d]pyrimidine-2,4(1H,3H) dione) phenoxy)
ethane 5c was found to possess good antibacterial activities.
Acknowledgments
The author expresses appreciation to the Islamic Azad Univer-
sity (Kerman Branch), for supporting this investigation.
Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/j.jscs.2016.
05.005.Please cite this article in press as: E. Sheikhhosseini, Design and eﬀective synthesis of
nal of Saudi Chemical Society (2016), http://dx.doi.org/10.1016/j.jscs.2016.05.005References
[1] R.G. Melik-Ogandzhanyan, V.E. Khachatryan, A.S. Gapoyan,
Furo-, thieno-, and pyrrolo-[2,3-d]pyrimidines, Russ. Chem.
Rev. 54 (1985) 262–276.
[2] J.H. DeMoe, S. Santaguida, J.R. Daum, A. Musacchio, G.J.
Gorbsky, A high throughput, whole cell screen for small
molecule inhibitors of the mitotic spindle checkpoint identifies
OM137, a novel Aurora kinase inhibitor, Cancer Res. 69 (2009)
1509–1516.
[3] J. Zhang, L.P. Yang, N.S. Gray, Targeting cancer with small
molecule kinase inhibitors, Nat. Rev. Cancer 9 (2009) 28–39.
[4] R.R. Frey, M.L. Curtin, D.H. Albert, K.B. Glaser, L.J. Pease,
N.B. Soni, J.J. Ouska, D. Reuter, K.D. Stewart, P. Marcotte, G.
Bukofzer, J. Li, S.K. Davidsen, M.R. Michaelides, 7-
Aminopyrazolo[1,5-a]pyrimidines as potent multitargeted
receptor tyrosine kinase inhibitors, J. Med. Chem. 51 (2008)
3777–3787.
[5] E. Campaigne, R.L. Ellis, M. Bradford, J. Ho, Synthesis of some
ureidodihydrofurans and related pyrimidones as potential
antimalarials, J. Med. Chem. 12 (1969) 339–342.
[6] A. Gangiee, Y. Zeng, J.J. MeGuire, F. Mehraein, R.L. Kisliuk,
Synthesis of classical, three-carbon-bridged 5-substituted furo
[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine
analogues as antifolates, J. Med. Chem. 47 (2004) 6893–6901.
[7] S. Furukawa, M. Takada, H.N. Castle, Pyrimidinylalkylthiols,
furo[2,3-d]pyrimidines and derivatives, J. Heterocycl. Chem. 18
(1981) 581–585.
[8] A. Gangjee, Y. Zeng, J.J. McGuri, R.L. Kisliuk, Effect of C9-
methyl substitution and C8–C9 conformational restriction on
antifolate and antitumor activity of classical 5-substituted 2,4-
diaminofuro[2,3-d]pyrimidines, J. Med. Chem. 43 (2000) 3125–
3133.
[9] A. Gangjee, R. Devraj, J.J. McGuri, R.R. Kisliuk, S.F. Queener,
L.R. Barrows, Classical and nonclassicalfuro[2,3-d]pyrimidines
as novel antifolates: synthesis and biological activities, J. Med.
Chem. 37 (1994) 1169–1176.
[10] C.J. Shishoo, K.S. Jain, Synthesis of some novel azido/
tetrazolothienopyrimidines and their reduction to 2,4-
diaminothieno[2,3-d]pyrimidines, J. Heterocycl. Chem. 29
(1992) 883–893.
[11] M.J. Robins, K. Miranda, V.K. Rajwanshi, M.A. Peterson, G.
Andrei, R. Snoeck, E. DeClercq, J. Balzarini, Synthesis and
biological evaluation of 6-(alkyn-1-yl)furo[2,3-d]pyrimidin-2
(3H)-one base and nucleoside derivatives, J. Med. Chem. 49
(2006) 391–398.
[12] A. Martin-Kohler, J. Widmer, G. Bold, T. Meyer, U. Se´quin, P.
Traxler, Furo[2,3-d]pyrimidines and oxazolo[5,4-d]pyrimidines
as inhibitors of receptor tyrosine kinases (RTK), Helv. Chem.
Acta 87 (2004) 956–975.
[13] C.L. Gibson, J.K. Huggan, A. Kennedy, L. Kiefer, J.H. Lee, C.
J. Suckling, C. Clements, A. Harvey, W.N. Hunter, T.B.
Tulloch, Diversity oriented syntheses of fused pyrimidinesnovel furo[2,3-d]pyrimidine derivatives containing ethylene ether spacers, Jour-
6 E. Sheikhhosseinidesigned as potential antifolates, Org. Biomol. Chem. 7 (2009)
1829–1842.
[14] A. Gangjee, H.D. Jain, J. Phan, X. Guo, S.F. Queener, R.L.
Kisliuk, 2,4-Diamino-5-methyl-6-substituted arylthio-furo[2,3-
d]pyrimidines as novel classical and nonclassical antifolates as
potential dual thymidylate synthase and dihydrofolate reductase
inhibitors, Bioorg. Med. Chem. 18 (2010) 953–961.
[15] A. Gangjee, W. Li, L. Lin, Y. Zeng, M. Ihnat, L.A. Warnke, D.
W. Green, V. Cody, J. Pace, S.F. Queener, Design, synthesis,
and X-ray crystal structures of 2,4-diaminofuro[2,3-d]
pyrimidines as multireceptor tyrosine kinase and
dihydrofolatereductase inhibitors, Bioorg. Med. Chem. 17
(2009) 7324–7336.
[16] J.D. Figueroa-Villar, C.L. Carneiro, E.R. Cruz, Synthesis of 6-
phenylaminofuro[2,3-d]pyrimidine-2,4-(1H,3H)-diones from
barbiturylbenzylidenes and isonitriles, Heterocycles 34 (1992)
891–894.
[17] E. Campaigne, R.L. Ellis, M. Bradford, J. Ho, Synthesis of some
ureidodihydrofurans and related pyrimidones as potential
antimalarials, J. Med. Chem. 12 (1996) 339–342.
[18] K. Kobayashi, H. Tanaka, K. Tanaka, K. Yoneda, O.
Morikawa, H. Konishi, One-step synthesis of furo[2,3-d]
pyrimidine-2,4(1H,3H)-diones using the can-mediated furan
ring formation, Synth. Commun. 30 (2000) 4277–4291.
[19] C.-Y. Qian, H. Nishino, K. Kurosawa, J.D. Korp, Manganese
(II) acetate-mediated double 2-hydroperoxyalkylations of
barbituric acid and its derivatives, J. Org. Chem. 58 (1993)
4448–4451.
[20] M.M. Shaker, The chemistry of mercapto- and thione-
substituted 1,2,4-triazoles and their utility in heterocyclic
synthesis, Arkivoc Xiv (2006) 59–112.
[21] A. Shaabani, M.B. Teimouri, H.R. Bijanzadeh, One-pot three
component condensation reaction in water: an efficient and
improved procedure for the synthesis of furo[2,3-d]pyrimidine-
2,4(1H,3H)-diones, Tetrahedron Lett. 43 (2002) 9151–9154.
[22] F. Shabani, S. Ghammamy, K. Mehrani, M.B. Teimouri, M.
Soleimani, S. Kaviani, Antitumor activity of 6-
(cyclohexylamino)-1,3-dimethyl-5(2-pyridyl)furo[2,3-d]
pyrimidine-2,4(1H,3H)-dione and its Ti(IV), Zn(II), Fe(III), and
Pd(II) complexes on K562 and jurkat cell lines, Bioinorg. Chem.
Appl. 2008 (2008) 5.
[23] D. Prajapati, M. Gohain, An efficient synthesis of novel pyrano
[2,3-d]-and furopyrano [2,3-d] pyrimidines via indium-catalyzedPlease cite this article in press as: E. Sheikhhosseini, Design and eﬀective synthesis of
nal of Saudi Chemical Society (2016), http://dx.doi.org/10.1016/j.jscs.2016.05.005multi-component domino reaction, Beilstein J. Org. Chem. 2
(2006) 4.
[24] M.B. Teimouria, R. Bazhrang, Shaken not stirred: a facile
synthesis of 1,4-bis(furo[2,3-d]-pyrimidine-2,4(1H,3H)-dione-5-
yl)benzenes by one-pot reaction of isocyanides, N,N0
dimethylbarbituric acid, and terephthaldialdehyde, Bioorg.
Med. Chem. Lett. 16 (2006) 3697–3701.
[25] I. Maisa, A. Moneam, A.A. Geies, G.M. El-Naggar, S.M.
Mousa, Synthesis of new furo[2,3-d]pyrimidines and pyrimido
[40,50:4,5]furo[2,3-d]pyrimidines, J. Chin. Chem. Soc. 51 (2004)
1357–1366.
[26] N.N. Pesyan, M. Jalilzade, Bifunctionalized linked bis-spiro
[furo[2,3-d]pyrimidine-6,5’-pyrimidine]2,2’,4,4’,6’(3H, 3’H, 5H)-
pentaones derived from one-pot reaction of (thio)barbituric
acids with aromatic dialdehydes and BrCN in the presence of
Et3N, Turk. J. Chem. 36 (2012) 788–804.
[27] S. Demirayak, U.A. Mohsen, A facile synthesis of some
thieno/furo [2,3-d] pyrimidine-2-yl-thioacetic acid derivatives,
J. Heterocycl. Chem. 38 (2001) 507–509.
[28] Y.-G. Hu, Y. Wang, S.-M. Du, X.-B. Chen, M.-W. Ding,
Efficient synthesis and biological evaluation of some 2,4-
diamino-furo[2,3-d]pyrimidine derivatives, Bioorg. Med. Chem.
Lett. 20 (2010) 6188–6190.
[29] M. Faryabi, E. Sheikhhosseini, Efficient synthesis of novel
benzylidene barbituric and thiobarbituric acid derivatives
containing ethyleneglycol spacers, J. Iran. Chem. Soc. 12
(2015) 427–432.
[30] A. Habibi, E. Sheikhhosseini, A. Shockravi, Synthesis of novel
furo-pyran derivatives via reaction between an isocyanide and
alkylidene-substituted Meldrum’s acid, Tetrahedron Lett. 50
(2009) 1075–1078.
[31] A. Habibi, E. Sheikhhosseini, N. Taghipoor, A simple and
efficient approach to the synthesis of furopyran derivatives:
four-component reaction of isocyanides with arylidene-
substituted Meldrum’s acid, Chem. Heterocycl. Compd. 49
(2013) 1040–1045.
[32] T.S. Mokhtari, E. Sheikhhosseini, M.A. Amrollahi, H. Sheibani,
A convenient one-pot synthesis of novel tetraamides via 2-
cyclopentylidenemalonic acid based Ugi-four component
reaction, J. Saudi Chem. Soc. (2015) (in press).
[33] J. Kim, M.R. Marshal, C. Wie, Antibacterial activity of some
essential oil components against five foodborne pathogens, J.
Agric. Food Chem. 43 (1995) 2839–2845.novel furo[2,3-d]pyrimidine derivatives containing ethylene ether spacers, Jour-
